From: Risk factors of recurrent erysipelas in adult Chinese patients: a prospective cohort study
Variable | NRE (n = 359) | RE (n = 69) | X2 | p value | OR (95%CI) |
---|---|---|---|---|---|
Age | 57.57 ± 17.55 | 63.12 ± 15.57 | – | 0.02 | – |
Gender | 0.215 | 0.64 | 1.1 (0.7–1.9) | ||
male | 167 (46.5) | 30 (43.5) | |||
female | 192 (53.5) | 39 (56.5) | |||
Anatomical areas | 9.01 | 0.03 | |||
lower limbs | 215 (59.9) | 54 (78.3) | 1 (reference) | ||
head/face | 61 (17.0) | 8 (11.6) | 0.5 (0.2–1.2) | ||
upper limbs | 49 13.6) | 5 (7.2) | 0.4 (0.2–1.0) | ||
trunk | 34 (9.5) | 2 (2.9) | 0.2 (0.1–0.9) | ||
Clinical types | 0.005 | 0.94 | 0.9 (0.3–2.8) | ||
vulgaris type | 341 (95.0) | 66 (95.7) | |||
other types | 18 (5.0) | 3 (4.3) | |||
Systemic symptoms | 147 (40.9) | 28 (40.6) | 0.003 | 0.95 | 1.0 (0.6–1.7) |
Disruption of Skin barrier | 45 (12.5) | 11 (15.9) | 0.591 | 0.44 | 1.3 (0.6–2.7) |
Surgery | 62 (17.3) | 32 (46.4) | 28.61 | < 0.0001 | 4.1 (2.4–7.1) |
Antibiotic varieties for first episode | 28.04 | < 0.0001 | 5.0 (2.6–9.3) | ||
penicillin | 330 (91.9) | 48 (69.6) | |||
other classes of antibiotics | 29 (8.1) | 21 (30.4) |